Found: 6
Select item for more details and to access through your institution.
Evaluation of the efficacy of pimavanserin in the treatment of agitation and aggression in patients with Alzheimer's disease psychosis: A post hoc analysis.
- Published in:
- International Journal of Geriatric Psychiatry, 2020, v. 35, n. 11, p. 1402, doi. 10.1002/gps.5381
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Darunavir and Etravirine in HIV-1-Infected, Treatment-Experienced Patients in the Gender, Race, and Clinical Experience (GRACE) Trial.
- Published in:
- AIDS Research & Treatment, 2012, p. 1, doi. 10.1155/2012/186987
- By:
- Publication type:
- Article
Safety profile of pimavanserin therapy in elderly patients with neurodegenerative disease‐related neuropsychiatric symptoms: a Phase 3b study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.076487
- By:
- Publication type:
- Article
P3‐002: PIMAVANSERIN IN ALZHEIMER'S DISEASE PSYCHOSIS: SUBGROUP ANALYSIS OF THE MORE SEVERE POPULATION.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1062, doi. 10.1016/j.jalz.2018.06.1357
- By:
- Publication type:
- Article
The effects of treatment with pimavanserin on activities of daily living in patients with Parkinson's disease psychosis: a 16-week, single-arm, open-label study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17562864241228350
- By:
- Publication type:
- Article
Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications.
- Published in:
- 2018
- By:
- Publication type:
- journal article